Ignite Creation Date:
2025-12-24 @ 5:45 PM
Ignite Modification Date:
2025-12-24 @ 5:45 PM
Study NCT ID:
NCT06794268
Status:
RECRUITING
Last Update Posted:
2025-02-24
First Post:
2025-01-20
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study to Patients With Relapsed/Refractory Follicular Lymphoma Treated With Liso-cel (Lisocabtagene Maraleucel) in the Post Marketing Setting
Sponsor:
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-02-04
Start Date Type:
ACTUAL
Primary Completion Date:
2044-08-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2044-08-31
Completion Date Type:
ESTIMATED
First Submit Date:
2025-01-20
First Submit QC Date:
None
Study First Post Date:
2025-01-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-21
Last Update Post Date:
2025-02-24
Last Update Post Date Type:
ACTUAL